Beyond the Leaves: What is Kratom?
Kratom, also known as Mitragyna speciosa, is an herbal leaf derived from tropical trees found in Southeast Asia.
Kratom has two primary ingredients: mitragynine and 7-OH-mitragynine. These ingredients work in the brain similar to some painkillers. They latch onto opioid receptors and also affect other brain systems that involve serotonin, dopamine, norepinephrine (these are chemicals that help our brain cells communicate and can affect our mood), and kappa opioid receptors.
Products made from kratom leaves are available in the U.S. through online sales and at physical stores such as gas stations. Kratom is sold in various forms, including powders, chewable tablets, gummies, and liquid formulations.
Side Effects & Safety Concerns
Kratom has become a hot topic lately, sparking quite a debate due to its potential side effects and safety concerns. While some people turn to Kratom for its stimulating effects, it’s crucial to be aware of the possible downsides. Users have reported experiencing issues like aggression, anxiety, nausea, and vomiting.
In more serious cases, healthcare professionals have observed a range of adverse effects, including seizures, psychiatric issues, cardiovascular problems, gastrointestinal distress, respiratory complications, and, in rare instances, even death.
The U.S. Drug Enforcement Administration (DEA) considers Kratom a drug of concern. Between 2014 and 2019, poison control centers in the U.S. received over 3,400 reports related to kratom use. The Substance Abuse and Mental Health Services Administration estimates 1.7 million Americans aged 12 and older used Kratom in 2021.
Combatting Kratom: Legality and Legislation
The FDA has not approved Kratom for sale in the U.S., and it operates in a legal grey area. Some states, including Alabama, have banned Kratom due to health concerns.
Recent court decisions regarding alleged kratom-related deaths have been tied to the failure of product manufacturers to provide labeling instructions for responsible use and to disclose little or no information on the actual contents.
Related News
Acetaminophen MDL Clients Get Favorable Ruling
U.S. District Judge Denise Cote in the Southern District of New York recently took significant…
Opioid multidistrict litigation, state cases updates
Lawyers in the opioid multidistrict litigation (MDL) debated in a hearing on Nov. 6 over…
School districts in three states file vaping lawsuits against JUUL Labs
Beasley Allen lawyers and co-counsel filed lawsuits on behalf of school districts in Kansas, Missouri,…